| Property |
Value |
| Protein Name |
3-Repeat Tau Isoform |
| Gene |
MAPT |
| UniProt ID |
P10636-8 |
| PDB Structures |
3QL4, 4NP8 |
| Molecular Weight |
45-68 kDa |
| Subcellular Localization |
Axons, neuronal soma |
| Protein Family |
MAPT family, microtubule-associated proteins |
3R-Tau refers to tau protein isoforms containing three microtubule-binding repeat domains, generated by alternative splicing of the MAPT gene. The tau protein is encoded by the MAPT gene on chromosome 17q21, and alternative splicing of exon 10 determines whether the protein contains three (3R) or four (4R) microtubule-binding repeats. This difference in isoform composition has significant implications for both normal neuronal function and the pathogenesis of various neurodegenerative diseases known as tauopathies.
3R-Tau isoforms are generated by exclusion of exon 10 during mRNA splicing:
- Repeat domain structure: Contains R1, R3, and R4 repeats (lacks R2)
- Microtubule-binding regions: Three hexapeptide motifs (275KVQIINKK280, 306VQIVYKPVDLSKVTSKC322)
- N-terminal inserts: Can have 0, 1, or 2 N-terminal inserts (0N, 1N, 2N isoforms)
- Total length: 352-381 amino acids depending on N-terminal splicing
- Proline-rich domain: Projecting N-terminal region that modulates interactions
- Repeat domain: Core microtubule-binding region
- C-terminal region: Involved in filament formation
- Phosphorylation sites: Multiple serine, threonine, and tyrosine residues
3R-Tau isoforms play essential roles in neuronal cells:
- Microtubule assembly: Promotes tubulin polymerization into microtubules
- Axonal transport: Supports bidirectional transport via motor proteins (kinesins, dyneins)
- Cytoskeletal stability: Maintains axonal architecture
- Synaptic function: Regulates synaptic vesicle trafficking
- Fetal expression: High levels in developing brain
- Adult expression: Reduced but maintained in specific neuronal populations
- Isoform switching: Transition from 3R to 4R during development
3R-Tau is a major component of neurofibrillary tangles in AD:
- Mixed pathology: AD brains contain approximately equal 3R and 4R tau
- NFT formation: Both 3R and 4R tau aggregate into paired helical filaments
- Braak staging: Tau pathology spreads in a predictable pattern
- Correlation with cognition: NFT burden correlates with cognitive decline
3R-Tau is predominant in Pick's disease:
- Pick bodies: Spherical tau inclusions composed primarily of 3R tau
- 3R-predominant: >90% of tau in Pick bodies is 3R isoform
- Behavioral variant FTD: Presents as behavioral disinhibition
- Sparing of other brain regions: Relative preservation vs. AD
- Chronic traumatic encephalopathy (CTE): Mixed 3R/4R pathology
- Down syndrome with AD: Early 3R-tau pathology
- Senile degeneration: Variable 3R/4R ratios
| Feature |
3R-Tau |
4R-Tau |
| Repeat domains |
R1, R3, R4 |
R1-R4 |
| Microtubule affinity |
Lower |
Higher |
| Aggregation propensity |
Similar |
Similar |
| Developmental expression |
Early |
Later |
| Adult brain ratio |
~50% |
~50% (AD) |
- Tau aggregation inhibitors: Target both 3R and 4R aggregation
- Anti-tau immunotherapies: Antibodies targeting phosphorylated tau
- Kinase inhibitors: Block tau-phosphorylating enzymes
- Splice-modulating therapies: Target exon 10 splicing
- Exon 10 splicing modulators: ASOs targeting splicing regulatory elements
- Isoform-specific antibodies: Potential for isoform-targeted therapy
- Biomarker development: 3R-tau-specific CSF markers
- Goedert, M. et al. (1992) Tau protein isoforms in neurodegeneration
- Spillantini, M.G. & Goedert, M. (2013) Tau pathology in neurodegenerative diseases
- Sergeant, N. et al. (2008) 3R-tau in Pick's disease